沈阳医学院学报2016，Vol.18Issue(3)：198-201,4.DOI:10.16753/j.cnki.1008-2344.2016.03.023
P CI时代急性心肌梗死患者接受β受体阻滞剂治疗的获益与应用策略
Benefit and Application of β-blocker Therapy for Patients with AMI in the Era of PCI
王纯田 1柯永胜1
作者信息
- 1. 皖南医学院弋矶山医院心内科，安徽 芜湖 241001
- 折叠
摘要
Abstract
[ Abstrct] Back in the 1980s, β⁃blockers was widely used because of decreased myocardial infarction mortality and protected heart function. In recent years, with the rapid development of percutaneous coronary intervention ( PCI) technology, the mortality of pa⁃tients with acute myocardial infarction ( AMI) significantly decreased. The issue of whether patients with AMI continue to benefit fromβ⁃blockers treatment is disputed. This review is aim to retrospect the researches about the effects ofβ⁃blockers on patients with AMI in aspects of myocardial infarct size, heart failure and mortality after AMI, meanwhile summarizing the rational use ofβ⁃blocker therapy in the PCI era.关键词
急性心肌梗死/β受体阻滞剂/经皮冠状动脉介入治疗Key words
acute myocardial infarction/β-blockers/percutaneous coronary intervention分类
医药卫生引用本文复制引用
王纯田,柯永胜..P CI时代急性心肌梗死患者接受β受体阻滞剂治疗的获益与应用策略[J].沈阳医学院学报,2016,18(3):198-201,4.
